Hydrogen nanobubbles: A novel approach toward radio-sensitization agents

Ocular melanoma is a rare kind of eye malignancy that threatens the patient's eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 ( Ru) ophthalmic plaques has been used f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical physics (Lancaster) 2023-10, Vol.50 (10), p.6589-6599
Hauptverfasser: Hashemi, Samaneh, Aghamiri, Seyed Mahmoud-Reza, Siavashpour, Zahra, Kahani, Mahdi, Zaidi, Habib, Jaberi, Ramin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6599
container_issue 10
container_start_page 6589
container_title Medical physics (Lancaster)
container_volume 50
creator Hashemi, Samaneh
Aghamiri, Seyed Mahmoud-Reza
Siavashpour, Zahra
Kahani, Mahdi
Zaidi, Habib
Jaberi, Ramin
description Ocular melanoma is a rare kind of eye malignancy that threatens the patient's eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 ( Ru) ophthalmic plaques has been used for decades to treat ocular melanoma, with the applicator placed on the patient's eyes until the prescribed dose reaches the tumor apex. To investigate the efficiency of hydrogen nanobubbles (H -NBs) employment during intraocular melanoma brachytherapy using a Ru electron emitter plaque. The Monte Carlo (MC) simulation and experimental investigation using a 3D-designed phantom and thermoluminescence dosimetry (TLD) were employed. Various concentrations of H -NBs with a diameter of 100 nm were simulated inside tumor tissue. The results were presented as deposited energy and dose enhancement factor (DEF). An equivalent Resin phantom of the human eyeball was made using AutoCAD and 3D-Printer technologies. The glass-bead TLDs dosimeter were employed and placed inside the phantom. Using a 1% concentration of H -NBs, a DEF of 93% and 98% were achieved at the tumor apex of 10 mm from the experimental setup and MC simulation, respectively. For simulated concentrations of 0.1%, 0.3%, 0.5%, 1%, and 4% H -NBs, a maximum dose enhancement of 154%, 174%, 188%, 200%, and 300% were achieved, respectively, and a dose reduction was seen at about 3 mm from the plaque surface. H -NBs can be used as an absorbed dose enhancer in Ru eye brachytherapy because of their unique physical characteristics. Reducing plaque implantation time on the patient's eye, reducing sclera absorbed dose, and decreasing the risk of patients' healthy organs irradiation are reported as some of the potential benefits of using H2-NBs.
doi_str_mv 10.1002/mp.16521
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2823043290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2823043290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c283t-cf73ad207fdd2dd4e460e0451dc17882334c8f2d2319e44608d511c9c9b4fb343</originalsourceid><addsrcrecordid>eNpFkLFOwzAQQC0EoqUg8QXII0vK-ew0CVtVFYpUiQVmy7EdCErsYCeg8vUEKDDdcO-eTo-QcwZzBoBXbTdnixTZAZmiyHgiEIpDMgUoRIIC0gk5ifEFABY8hWMy4RlmORfplGw2OxP8k3XUKefLoSwbG6_pkjr_Zhuqui54pZ9p799VMDQoU_skWhfrvv5Qfe0dVeN1H0_JUaWaaM_2c0Yeb9YPq02yvb-9Wy23icac94muMq4MQlYZg8YIKxZgQaTMaJblOXIudF6hQc4KK8ZlblLGdKGLUlQlF3xGLn-842Ovg429bOuobdMoZ_0QJY4OEBwL-Ed18DEGW8ku1K0KO8lAfnWTbSe_u43oxd46lK01f-BvKP4Jfjtn0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823043290</pqid></control><display><type>article</type><title>Hydrogen nanobubbles: A novel approach toward radio-sensitization agents</title><source>Wiley-Blackwell Journals</source><source>Alma/SFX Local Collection</source><creator>Hashemi, Samaneh ; Aghamiri, Seyed Mahmoud-Reza ; Siavashpour, Zahra ; Kahani, Mahdi ; Zaidi, Habib ; Jaberi, Ramin</creator><creatorcontrib>Hashemi, Samaneh ; Aghamiri, Seyed Mahmoud-Reza ; Siavashpour, Zahra ; Kahani, Mahdi ; Zaidi, Habib ; Jaberi, Ramin</creatorcontrib><description>Ocular melanoma is a rare kind of eye malignancy that threatens the patient's eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 ( Ru) ophthalmic plaques has been used for decades to treat ocular melanoma, with the applicator placed on the patient's eyes until the prescribed dose reaches the tumor apex. To investigate the efficiency of hydrogen nanobubbles (H -NBs) employment during intraocular melanoma brachytherapy using a Ru electron emitter plaque. The Monte Carlo (MC) simulation and experimental investigation using a 3D-designed phantom and thermoluminescence dosimetry (TLD) were employed. Various concentrations of H -NBs with a diameter of 100 nm were simulated inside tumor tissue. The results were presented as deposited energy and dose enhancement factor (DEF). An equivalent Resin phantom of the human eyeball was made using AutoCAD and 3D-Printer technologies. The glass-bead TLDs dosimeter were employed and placed inside the phantom. Using a 1% concentration of H -NBs, a DEF of 93% and 98% were achieved at the tumor apex of 10 mm from the experimental setup and MC simulation, respectively. For simulated concentrations of 0.1%, 0.3%, 0.5%, 1%, and 4% H -NBs, a maximum dose enhancement of 154%, 174%, 188%, 200%, and 300% were achieved, respectively, and a dose reduction was seen at about 3 mm from the plaque surface. H -NBs can be used as an absorbed dose enhancer in Ru eye brachytherapy because of their unique physical characteristics. Reducing plaque implantation time on the patient's eye, reducing sclera absorbed dose, and decreasing the risk of patients' healthy organs irradiation are reported as some of the potential benefits of using H2-NBs.</description><identifier>ISSN: 0094-2405</identifier><identifier>EISSN: 2473-4209</identifier><identifier>DOI: 10.1002/mp.16521</identifier><identifier>PMID: 37278345</identifier><language>eng</language><publisher>United States</publisher><ispartof>Medical physics (Lancaster), 2023-10, Vol.50 (10), p.6589-6599</ispartof><rights>2023 American Association of Physicists in Medicine.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c283t-cf73ad207fdd2dd4e460e0451dc17882334c8f2d2319e44608d511c9c9b4fb343</citedby><cites>FETCH-LOGICAL-c283t-cf73ad207fdd2dd4e460e0451dc17882334c8f2d2319e44608d511c9c9b4fb343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37278345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashemi, Samaneh</creatorcontrib><creatorcontrib>Aghamiri, Seyed Mahmoud-Reza</creatorcontrib><creatorcontrib>Siavashpour, Zahra</creatorcontrib><creatorcontrib>Kahani, Mahdi</creatorcontrib><creatorcontrib>Zaidi, Habib</creatorcontrib><creatorcontrib>Jaberi, Ramin</creatorcontrib><title>Hydrogen nanobubbles: A novel approach toward radio-sensitization agents</title><title>Medical physics (Lancaster)</title><addtitle>Med Phys</addtitle><description>Ocular melanoma is a rare kind of eye malignancy that threatens the patient's eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 ( Ru) ophthalmic plaques has been used for decades to treat ocular melanoma, with the applicator placed on the patient's eyes until the prescribed dose reaches the tumor apex. To investigate the efficiency of hydrogen nanobubbles (H -NBs) employment during intraocular melanoma brachytherapy using a Ru electron emitter plaque. The Monte Carlo (MC) simulation and experimental investigation using a 3D-designed phantom and thermoluminescence dosimetry (TLD) were employed. Various concentrations of H -NBs with a diameter of 100 nm were simulated inside tumor tissue. The results were presented as deposited energy and dose enhancement factor (DEF). An equivalent Resin phantom of the human eyeball was made using AutoCAD and 3D-Printer technologies. The glass-bead TLDs dosimeter were employed and placed inside the phantom. Using a 1% concentration of H -NBs, a DEF of 93% and 98% were achieved at the tumor apex of 10 mm from the experimental setup and MC simulation, respectively. For simulated concentrations of 0.1%, 0.3%, 0.5%, 1%, and 4% H -NBs, a maximum dose enhancement of 154%, 174%, 188%, 200%, and 300% were achieved, respectively, and a dose reduction was seen at about 3 mm from the plaque surface. H -NBs can be used as an absorbed dose enhancer in Ru eye brachytherapy because of their unique physical characteristics. Reducing plaque implantation time on the patient's eye, reducing sclera absorbed dose, and decreasing the risk of patients' healthy organs irradiation are reported as some of the potential benefits of using H2-NBs.</description><issn>0094-2405</issn><issn>2473-4209</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpFkLFOwzAQQC0EoqUg8QXII0vK-ew0CVtVFYpUiQVmy7EdCErsYCeg8vUEKDDdcO-eTo-QcwZzBoBXbTdnixTZAZmiyHgiEIpDMgUoRIIC0gk5ifEFABY8hWMy4RlmORfplGw2OxP8k3XUKefLoSwbG6_pkjr_Zhuqui54pZ9p799VMDQoU_skWhfrvv5Qfe0dVeN1H0_JUaWaaM_2c0Yeb9YPq02yvb-9Wy23icac94muMq4MQlYZg8YIKxZgQaTMaJblOXIudF6hQc4KK8ZlblLGdKGLUlQlF3xGLn-842Ovg429bOuobdMoZ_0QJY4OEBwL-Ed18DEGW8ku1K0KO8lAfnWTbSe_u43oxd46lK01f-BvKP4Jfjtn0Q</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Hashemi, Samaneh</creator><creator>Aghamiri, Seyed Mahmoud-Reza</creator><creator>Siavashpour, Zahra</creator><creator>Kahani, Mahdi</creator><creator>Zaidi, Habib</creator><creator>Jaberi, Ramin</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231001</creationdate><title>Hydrogen nanobubbles: A novel approach toward radio-sensitization agents</title><author>Hashemi, Samaneh ; Aghamiri, Seyed Mahmoud-Reza ; Siavashpour, Zahra ; Kahani, Mahdi ; Zaidi, Habib ; Jaberi, Ramin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c283t-cf73ad207fdd2dd4e460e0451dc17882334c8f2d2319e44608d511c9c9b4fb343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashemi, Samaneh</creatorcontrib><creatorcontrib>Aghamiri, Seyed Mahmoud-Reza</creatorcontrib><creatorcontrib>Siavashpour, Zahra</creatorcontrib><creatorcontrib>Kahani, Mahdi</creatorcontrib><creatorcontrib>Zaidi, Habib</creatorcontrib><creatorcontrib>Jaberi, Ramin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical physics (Lancaster)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashemi, Samaneh</au><au>Aghamiri, Seyed Mahmoud-Reza</au><au>Siavashpour, Zahra</au><au>Kahani, Mahdi</au><au>Zaidi, Habib</au><au>Jaberi, Ramin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydrogen nanobubbles: A novel approach toward radio-sensitization agents</atitle><jtitle>Medical physics (Lancaster)</jtitle><addtitle>Med Phys</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>50</volume><issue>10</issue><spage>6589</spage><epage>6599</epage><pages>6589-6599</pages><issn>0094-2405</issn><eissn>2473-4209</eissn><abstract>Ocular melanoma is a rare kind of eye malignancy that threatens the patient's eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 ( Ru) ophthalmic plaques has been used for decades to treat ocular melanoma, with the applicator placed on the patient's eyes until the prescribed dose reaches the tumor apex. To investigate the efficiency of hydrogen nanobubbles (H -NBs) employment during intraocular melanoma brachytherapy using a Ru electron emitter plaque. The Monte Carlo (MC) simulation and experimental investigation using a 3D-designed phantom and thermoluminescence dosimetry (TLD) were employed. Various concentrations of H -NBs with a diameter of 100 nm were simulated inside tumor tissue. The results were presented as deposited energy and dose enhancement factor (DEF). An equivalent Resin phantom of the human eyeball was made using AutoCAD and 3D-Printer technologies. The glass-bead TLDs dosimeter were employed and placed inside the phantom. Using a 1% concentration of H -NBs, a DEF of 93% and 98% were achieved at the tumor apex of 10 mm from the experimental setup and MC simulation, respectively. For simulated concentrations of 0.1%, 0.3%, 0.5%, 1%, and 4% H -NBs, a maximum dose enhancement of 154%, 174%, 188%, 200%, and 300% were achieved, respectively, and a dose reduction was seen at about 3 mm from the plaque surface. H -NBs can be used as an absorbed dose enhancer in Ru eye brachytherapy because of their unique physical characteristics. Reducing plaque implantation time on the patient's eye, reducing sclera absorbed dose, and decreasing the risk of patients' healthy organs irradiation are reported as some of the potential benefits of using H2-NBs.</abstract><cop>United States</cop><pmid>37278345</pmid><doi>10.1002/mp.16521</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0094-2405
ispartof Medical physics (Lancaster), 2023-10, Vol.50 (10), p.6589-6599
issn 0094-2405
2473-4209
language eng
recordid cdi_proquest_miscellaneous_2823043290
source Wiley-Blackwell Journals; Alma/SFX Local Collection
title Hydrogen nanobubbles: A novel approach toward radio-sensitization agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydrogen%20nanobubbles:%20A%20novel%20approach%20toward%20radio-sensitization%20agents&rft.jtitle=Medical%20physics%20(Lancaster)&rft.au=Hashemi,%20Samaneh&rft.date=2023-10-01&rft.volume=50&rft.issue=10&rft.spage=6589&rft.epage=6599&rft.pages=6589-6599&rft.issn=0094-2405&rft.eissn=2473-4209&rft_id=info:doi/10.1002/mp.16521&rft_dat=%3Cproquest_cross%3E2823043290%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823043290&rft_id=info:pmid/37278345&rfr_iscdi=true